Sterile pharmaceutical company that develops injectable and ophthalmic drugs
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
240
NCT06771063
A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 13, 2025
Completion: Jul 31, 2025
NCT07065968
The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
Role: Collaborator
Start: Aug 19, 2025
Completion: Dec 30, 2027
Loading map...